FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387012004: Zaleplon (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461190016 Zaleplon (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481126010 Zaleplon en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
374771000195114 zaleplon it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
850121000172111 zaléplone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zaleplon (substance) Is a Sedative (substance) true Inferred relationship Some
Zaleplon (substance) Is a classe d'allergènes false Inferred relationship Some
Zaleplon (substance) Is a allergène médicamenteux false Inferred relationship Some
Zaleplon (substance) Is a Substance with gamma-aminobutyric acid A receptor agonist mechanism of action (substance) true Inferred relationship Some
Zaleplon (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Gamma-aminobutyric acid A receptor agonist (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing zaleplon (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zaleplon (substance) Inferred relationship Some 1
Zaleplon 5 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zaleplon (substance) Inferred relationship Some
Zaleplon 10 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zaleplon (substance) Inferred relationship Some
Zaleplon 5 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zaleplon (substance) Inferred relationship Some 1
Zaleplon 5 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Zaleplon (substance) Inferred relationship Some 1
Zaleplon 10 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zaleplon (substance) Inferred relationship Some 1
Zaleplon 10 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Zaleplon (substance) Inferred relationship Some 1
Zaleplon 5 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Zaleplon (substance) Inferred relationship Some 1
Zaleplon 10 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Zaleplon (substance) Inferred relationship Some 1
Zaleplon-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zaleplon (substance) Inferred relationship Some 1
Zaleplon only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zaleplon (substance) Inferred relationship Some 1
Product containing only zaleplon in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zaleplon (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start